Overview
Aravon Injection contains Edaravone 1.5 mg, a neuroprotective agent used primarily to treat patients with amyotrophic lateral sclerosis (ALS). Edaravone acts as a free radical scavenger, reducing oxidative stress and helping to protect nerve cells from damage. This medication is administered intravenously and aims to slow the progression of neurological decline in ALS.





